The volatile anaesthetic agents are known to influence uterine muscle tone. All of the agents studied to date have been found to produce uterine relaxation. This property has been used to produce therapeutic uterine relaxation for difficult obstetric deliveries and the Ex Utero Intrapartum Treatment (EXIT) procedure. This study describes the effects of sevoflurane on isolated human myometrium at concentrations of 0.1, 0.25, 0.5, 0.75, 1.0, 1.5, 2.5 and 3.5 MAC. Sevoflurane produces dose-dependent depression of uterine muscle contractility with an ED50of 0.94 MAC. Frequency of contraction was increased at concentrations of 2.5 MAC and greater. At concentrations of 3.5 MAC and above, uterine activity was virtually abolished.
PengA.T., GormanR.S., ShulmanS.M., DeMarchisE., NyuntK., BlancatoL.S.Intravenous nitroglycerin for uterine relaxation in the postpartum patient with retained placenta.Anesthesiology1989; 71: 172–173.
2.
MayerD.C., WeeksS.K.Antepartum uterine relaxation with nitroglycerin at caeserean delivery.Can J Anaesth1992; 39: 166–169.
3.
AltabefK.M., SpencerJ.T., ZinbergS.Intravenous nitroglycerin for uterine relaxation of an inverted uterus.Am J Obstet Gynecol1992; 166: 1237–1238.
4.
DufourP., VinatierD., VandersticheleS., DucoyA.S., DepretS., MonnierJ.C.Intravenous nitroglycerine for internal podalic version of the second twin in transverse lie.Obstet Gynecol1998; 92: 416–419.
5.
LiechtyK.W., CrombleholmeT.M., FlakeA.W.Intrapartum airway management for giant fetal neck masses: the EXIT (ex utero intrapartum treatment) procedure.Am J Obstet Gynecol1997; 177: 870–874.
6.
LiechtyK.W., CrombleholmeT.M., WeinerS., BernickB., FlakeA.W., AdzickN.S.The ex utero intrapartum treatment procedure for a large fetal neck mass in a twin gestation.Obstet Gynecol1999; 93: 824–825.
7.
MunsonE.S., EmbroW.J.Enflurane, isoflurane and halothane and isolated human uterine muscle.Anesthesiology1977; 46: 11–14.
8.
BehneM., WilkeH.J., HarderS.Clinical pharmacokinetics of sevoflurane.Clin Pharmacokinet1999; 36: 13–26.
9.
FrinkE.J.Jr., MalanT.P., AtlasM., DominguezL.M., DiNardoJ.A., BrownBRJr.. Clinical comparison of sevoflurane and isoflu-rane in healthy patients.Anesth Analg1992; 74: 241–245.
10.
SchellerM.S., SaidmanL.J., PartridgeB.L.MAC of sevoflurane in humans and the New Zealand white rabbit.Can J Anaesth1988; 35: 153–156.
11.
MayerD.C., SpielmanF.J.Antepartum and postpartum hemorrhage. In: Obstetric Anesthesia.ChestnutD.H., ed. Mosby, St Louis1999; pp. 725–749.
12.
McMorlandG.H., EfferS.B.Breech presentation, malpresentation, multiple gestation. In: Anesthetic and obstetric management of high-risk pregnancy.DattaS. ed. St Louis: Mosby Year Book, 1991 pp. 74–89.
13.
TakauchiY., InamoriN., OhashiY.Anesthetic management for cesarean section in two parturients with quintuplet gestation.Masui1993; 42: 1844–1848.
DavidM., HalleH., LichteneggerW., SinhaP., ZimmermannT.Nitroglycerin to facilitate fetal extraction during cesarean section.Obstet Gynecol1998; 91: 119–124.
17.
ZagorzyckiM.T.General anesthesia in cesarean section: effect on mother and neonate.Obstet Gynecol Surv1984; 39: 134–137.
18.
CullenB.F., MargolisA.J., EgerEI2nd. The effects of anaesthesia and pulmonary ventilation on blood loss during elective therapeutic abortion.Anesthesiology1970; 32: 108–113.
19.
MoirD.D., WallaceG.Blood loss at forceps delivery.J Obstet Gynaecol Br Commonw1967; 74: 424–429.
20.
MoirD.D.Anaesthesia for Caesarean section. An evaluation of a method using low concentrations of halothane and 50% oxygen.Br J Anaesth1970; 42: 136–142.
21.
LarsenM.E., LarsenJ.W., HamersleyS.L., McBrideT.P., BahadoriR.S.Successful management of fetal cervical teratoma using the EXIT procedure.J Matern Fetal Med1999; 8: 295–297.
22.
ShihG.H., BoydG.L., VincentR.D.Jr., LongG.W., HauthJ.C., GeorgesonK.E.The EXIT procedure facilitates delivery of an infant with a pretracheal teratoma.Anesthesiology1998; 89: 1573–1575.
23.
GaiserR.R., CheekT.G., KurthC.D.Anesthetic management of cesarean delivery complicated by ex utero intrapartum treatment of the fetus.Anesth Analg1997; 84: 1150–1153.
24.
PaullJ., ZicconeS.Halothane, enflurane, methoxyflurane and isolated human uterine muscle.Anaesth Intensive Care1980; 8: 397–401.
25.
NaftalinN.J., McKayD.M., PhearW.P., GoldbergA.H.The effects of halothane on pregnant and nonpregnant human myometrium.Anesthesiology1977; 46: 15–19.
26.
McDonald-GibsonW.J.The influence of halothane (Fluothane) on isolated human uterine muscle.J Obstet Gynaecol Br Commonw1969; 76: 362–365.
27.
MillerJ.R., StoeltingV.K., StanderR.W., WatringW.In vitro and in vivo responses of the uterus to halothane anesthesia.Anesth Analg1966; 45: 583–589.
28.
YamakageM., TsujiguchiN., ChenX., KamadaY., NamikiA.Sevoflurane inhibits contraction of uterine smooth muscle from pregnant rats similarly to halothane and isoflurane.Can J Anesth2002; 49: 62–66.
29.
MunsonE.S., MaierW.R., CatonD.Effects of halothane, cyclopropane and nitrous oxide on isolated human uterine muscle.J Obstet Gynaecol Br Commonw1969; 76: 27–33.
30.
EbertT.J., FrinkE.J.Jr., KharaschE.D.Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers.Anesthesiology1998; 88: 601–610.
31.
KafaliH., KayaT., GursoyS., BagcivanI., KaradasB., SariogluY.The role of potassium channels on the inhibitor effect of sevoflurane in pregnant rat myometrium.Anesth Analg2002; 94: 174–178.
32.
LaszloA., BuljubasicN., ZsolnaiB., KampineJ.P., BosnjakZ.J.Interactive effects of volatile anesthetics, verapamil, and ryanodine on contractility and calcium homeostasis of isolated pregnant rat myometrium.Am J Obstet Gynecol1992; 167: 804–810.
33.
MiyoshiH., BoyleM.B., McKayL.B., GarfieldR.E.Voltage-clamp studies of gap junctions between uterine muscle cells during term and preterm labor.Biophys J1996; 71: 1324–1334.
